1-20 of 206
Gordon B. Mills
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3445: Immune cells infiltration and activation are higher in breast cancers resistant to antiestrogen therapy

Fabiana Napolitano, Dhivya R. Sudhan, Yunguan Wang, Paula I. González-Ericsson, Luigi Formisano, Kyung-Min Lee, Chang-Ching Lin, María Rosario Chica-Parrado, Hongli Ma, Nathaniel Evans, Alberto Servetto, Saurabh Mendiratta, Spencer Barnes, Yisheng V. Fang, Justin M. Balko, Gordon B. Mills, Marilyne Labrie, Ariella B. Hanker, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 3445.
https://doi.org/10.1158/1538-7445.AM2023-3445
Published: 04 April 2023
View article titled, Abstract 3445: Immune cells infiltration and activation are higher in breast cancers resistant to antiestrogen therapy
Journal Articles

Abstract 6618: Longitudinal, multimodal profiling of metastatic ER+ breast cancer on CDK4/6 inhibitor therapy

Allison L. Creason, Julian Egger, Cameron Watson, Shamilene Sivagnanam, Jia-Ren Lin, Koei Chin, Peter K. Sorger, Lisa M. Coussens, Zahi I. Mitri, Joe W. Gray, Gordon B. Mills, Jeremy Goecks
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 6618.
https://doi.org/10.1158/1538-7445.AM2023-6618
Published: 04 April 2023
View article titled, Abstract 6618: Longitudinal, multimodal profiling of metastatic ER+ breast cancer on CDK4/6 inhibitor therapy
Journal Articles

Abstract 5610: [18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-inhibitor drug-target engagement as a biomarker of response in ovarian cancer

Sarah B. Gitto, Austin R. Pantel, Mehran Makvandi, Hyoung Kim, Sergey Medvedev, Joanna K. Weeks, Drew A. Torigian, Chia-Ju Hsieh, Benjamin Ferman, Nawar A. Latif, Janos L. Tanyi, Lainie P. Martin, Shannon M. Lanzo, Fang Liu, Quy Cao, Gordon B. Mills, Robert K. Doot, David A. Mankoff, Robert H. Mach, Lilie L. Lin, Fiona Simpkins
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 5610.
https://doi.org/10.1158/1538-7445.AM2023-5610
Published: 04 April 2023
View article titled, Abstract 5610: [<sup>18</sup>F]FluorThanatrace ([<sup>18</sup>F]FTT) PET Imaging of PARP-inhibitor drug-target engagement as a biomarker of response in ovarian cancer
Journal Articles

Abstract 4916: Spatial analysis of local drug induced changes in tumor microenvironment predicts effective treatment combinations in breast cancer

Zuzana Tatarova, Dylan C. Blumberg, Gordon B. Mills, Lisa M. Coussens, Oliver Jonas, Joe W. Gray
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4916.
https://doi.org/10.1158/1538-7445.AM2023-4916
Published: 04 April 2023
View article titled, Abstract 4916: Spatial analysis of local drug induced changes in tumor microenvironment predicts effective treatment combinations in breast cancer
Journal Articles

Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer

Xu Hua, Yongsheng Li, Sairahul R. Pentaparthi, Daniel J. McGrail, Raymond Zou, Li Guo, Aditya Shrawat, Kara M. Cirillo, Qing Li, Akshay Bhat, Min Xu, Dan Qi, Ashok Singh, Francis McGrath, Steven Andrews, Kyaw Lwin Aung, Jishnu Das, Yunyun Zhou, Alessia Lodi, Gordon B. Mills, S. Gail Eckhardt, Marc L. Mendillo, Stefano Tiziani, Erxi Wu, Jason H. Huang, Nidhi Sahni, S. Stephen Yi
Journal: Cancer Research
Cancer Res (2023) 83 (1): 59–73.
https://doi.org/10.1158/0008-5472.CAN-20-0371
Published: 04 January 2023
View article titled, Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
Open the PDF for Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 3935: The polymeric fluoropyrimidine CF10 overcomes limitations of 5-FU in pancreatic ductal adenocarcinoma cells through increased replication stress

Roberto DiNiro, Alex O. Haber, Kang J. Jeong, Soon Y. Park, Gordon B. Mills, William H. Gmeiner, Jonathan R. Brody
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3935.
https://doi.org/10.1158/1538-7445.AM2022-3935
Published: 15 June 2022
View article titled, Abstract 3935: The polymeric fluoropyrimidine CF10 overcomes limitations of 5-FU in pancreatic ductal adenocarcinoma cells through increased replication stress
Journal Articles

Abstract 2149: Biomarker-driven selection of polyADP ribose polymerase inhibitors (PARPi)-based combination therapies in patients with metastatic triple negative breast cancer (mTNBC)

Zahi I. Mitri, Evthokia A. Hobbs, Shaun M. Goodyear, Jeong Youn Lim, Joanna Pucilowska, Brett Johnson, Allison L. Creason, Courtney Betts, Lisa M. Coussens, Shannon McWeeney, Christopher L. Corless, Joe W. Gray, Gordon B. Mills
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2149.
https://doi.org/10.1158/1538-7445.AM2022-2149
Published: 15 June 2022
View article titled, Abstract 2149: Biomarker-driven selection of polyADP ribose polymerase inhibitors (PARPi)-based combination therapies in patients with metastatic triple negative breast cancer (mTNBC)
Journal Articles

Abstract 3233: Interleukin enhancer-binding factor 2 amplification controls mRNA stability and enhances DNA damage response in metastatic melanoma

Xiaoqing Zhang, Matias A. Bustos, Rebecca Gross, Romela Irene Ramos, Teh-Ling Takeshima, Gordon B. Mills, Qiang Yu, Dave S. Hoon
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3233.
https://doi.org/10.1158/1538-7445.AM2022-3233
Published: 15 June 2022
View article titled, Abstract 3233: Interleukin enhancer-binding factor 2 amplification controls mRNA stability and enhances DNA damage response in metastatic melanoma
Journal Articles

Abstract P5-13-05: Multiplex spatial systems analysis of responses to spatially separate nanoliter doses of drug predicts systemic immune-modulating combination treatments in breast cancer

Zuzana Tatarova, Dylan C Blumberg, Lisa M Coussens, Gordon B Mills, Oliver Jonas, Joe W Gray
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P5-13-05.
https://doi.org/10.1158/1538-7445.SABCS21-P5-13-05
Published: 15 February 2022
View article titled, Abstract P5-13-05: Multiplex spatial systems analysis of responses to spatially separate nanoliter doses of drug predicts systemic immune-modulating combination treatments in breast cancer
Journal Articles

Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance

Jianglan Liu, Vito W. Rebecca, Andrew V. Kossenkov, Thomas Connelly, Qin Liu, Alexis Gutierrez, Min Xiao, Ling Li, Gao Zhang, Anastasia Samarkina, Delaine Zayasbazan, Jie Zhang, Chaoran Cheng, Zhi Wei, Gretchen M. Alicea, Mizuho Fukunaga-Kalabis, Clemens Krepler, Pedro Aza-Blanc, Chih-Cheng Yang, Bela Delvadia, Cynthia Tong, Ye Huang, Maya Delvadia, Alice S. Morias, Katrin Sproesser, Patricia Brafford, Joshua X. Wang, Marilda Beqiri, Rajasekharan Somasundaram, Adina Vultur, Denitsa M. Hristova, Lawrence W. Wu, Yiling Lu, Gordon B. Mills, Wei Xu, Giorgos C. Karakousis, Xiaowei Xu, Lynn M. Schuchter, Tara C. Mitchell, Ravi K. Amaravadi, Lawrence N. Kwong, Dennie T. Frederick, Genevieve M. Boland, Joseph M. Salvino, David W. Speicher, Keith T. Flaherty, Ze'ev A. Ronai, Meenhard Herlyn
Journal: Cancer Research
Cancer Res (2021) 81 (20): 5230–5241.
https://doi.org/10.1158/0008-5472.CAN-20-1496
Published: 15 October 2021
View article titled, Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance
Open the PDF for Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance in another window
Includes: Supplementary data
Journal Articles

Abstract LB010: SMMART Program: A multi-omics tumor board with a focus on breast cancer

Ben L. Kong, Brett E. Johnson, Jamie M. Keck, Souraya Mitri, Patrick Leyshock, Jayne M. Stommel, Kiara Siex, Marlana Klinger, Christina L. Zheng, Rochelle Williams-Belizaire, Shannon McWeeney, Jeremy Goecks, Annette Kolodzie, Alexander R. Guimaraes, George V. Thomas, Christopher L. Corless, Zahi I. Mitri, Joe W. Gray, Gordon B. Mills, Raymond C. Bergan
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): LB010.
https://doi.org/10.1158/1538-7445.AM2021-LB010
Published: 01 July 2021
View article titled, Abstract LB010: SMMART Program: A multi-omics tumor board with a focus on breast cancer
Journal Articles

MEK Inhibition Remodels the Immune Landscape of Mutant KRAS Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors

Bin Yang, Xi Li, Yu Fu, Ensong Guo, Youqiong Ye, Fuxia Li, Si Liu, Rourou Xiao, Chen Liu, Funian Lu, Jia Huang, Tianyu Qin, Leng Han, Guang Peng, Gordon B. Mills, Chaoyang Sun, Gang Chen
Journal: Cancer Research
Cancer Res (2021) 81 (10): 2714–2729.
https://doi.org/10.1158/0008-5472.CAN-20-2370
Published: 15 May 2021
View article titled, MEK Inhibition Remodels the Immune Landscape of Mutant <em>KRAS</em> Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors
Open the PDF for MEK Inhibition Remodels the Immune Landscape of Mutant <em>KRAS</em> Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors in another window
Includes: Supplementary data
Journal Articles

Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling

Deepak Parashar, Bindu Nair, Anjali Geethadevi, Jasmine George, Ajay Nair, Shirng-Wern Tsaih, Ishaque P. Kadamberi, Gopa Kumar Gopinadhan Nair, Yiling Lu, Ramani Ramchandran, Denise S. Uyar, Janet S. Rader, Prahlad T. Ram, Gordon B. Mills, Sunila Pradeep, Pradeep Chaluvally-Raghavan
Journal: Cancer Research
Cancer Res (2020) 80 (24): 5554–5568.
https://doi.org/10.1158/0008-5472.CAN-19-3717
Published: 15 December 2020
View article titled, Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling
Open the PDF for Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling in another window
Includes: Supplementary data
Journal Articles

Integrated Genomic Characterization of the Human Immunome in Cancer

Yongsheng Li, Brandon Burgman, Daniel J. McGrail, Ming Sun, Dan Qi, Sachet A. Shukla, Erxi Wu, Anna Capasso, Shiaw-Yih Lin, Catherine J. Wu, S. Gail Eckhardt, Gordon B. Mills, Bo Li, Nidhi Sahni, S. Stephen Yi
Journal: Cancer Research
Cancer Res (2020) 80 (21): 4854–4867.
https://doi.org/10.1158/0008-5472.CAN-20-0384
Published: 03 November 2020
View article titled, Integrated Genomic Characterization of the Human Immunome in Cancer
Open the PDF for Integrated Genomic Characterization of the Human Immunome in Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract PR03: Nongenomic BAP1 aberrancy drives highly aggressive cutaneous melanoma phenotype

Haifeng Zhu, Junna Oba, Xiaoxing Yu, Caitlin A. Creasy, Marie-Andrée Forget, Fernando Carapeto, Cara L. Haymaker, Chang-Jiun Wu, Tatiana V. Karpinets, Wei-Lien Wang, Michael T. Tetzlaff, Alexander J. Lazar, Gordon B. Mills, Amanda R. Moore, Yu Chen, Jianhua Zhang, Jeffrey E. Gershenwald, Jennifer A. Wargo, Chantale Bernatchez, Patrick Hwu, P. Andrew Futreal, Scott E. Woodman
Journal: Cancer Research
Cancer Res (2020) 80 (19_Supplement): PR03.
https://doi.org/10.1158/1538-7445.MEL2019-PR03
Published: 02 October 2020
View article titled, Abstract PR03: Nongenomic BAP1 aberrancy drives highly aggressive cutaneous melanoma phenotype
Journal Articles

Abstract 2941: Functional proteomic aberrations post-chemotherapy with paclitaxel and carboplatin in patients with advanced ovarian cancer

Sanghoon Lee, Li Zhao, Joseph Celestino, Kelly M. Rangel, Richard A. Hajek, Mark S. Kim, Sara E. Sharafi, Jinsong Liu, Nicole D. Fleming, Karen H. Lu, Jianhua Zhang, P. Andrew Futreal, Gordon B. Mills, Shannon N. Westin, Anil K. Sood, Amir A. Jazaeri, Robert L. Coleman
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 2941.
https://doi.org/10.1158/1538-7445.AM2020-2941
Published: 15 August 2020
View article titled, Abstract 2941: Functional proteomic aberrations post-chemotherapy with paclitaxel and carboplatin in patients with advanced ovarian cancer
Journal Articles

Abstract 3052: Targeting AXL in PIK3R2-amplified ovarian cancer

Ling Rao, Victor C. Mak, Yuan Zhou, Dong Zhang, Xinran Li, Yiling Lu, Gordon B. Mills, Lydia W. Cheung
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 3052.
https://doi.org/10.1158/1538-7445.AM2020-3052
Published: 15 August 2020
View article titled, Abstract 3052: Targeting AXL in <em>PIK3R2</em>-amplified ovarian cancer
Journal Articles

Abstract CT143: Phase I study of the combination of a RAF-MEK inhibitor CH5126766 and FAK inhibitor defactinib in an intermittent dosing schedule with expansions in KRAS mutant cancers

Rajiv Shinde, Angelika Terbuch, Martin Little, Reece Caldwell, Roopa Kurup, Ruth Riisnaes, Mateus Crespo, Ruth Ruddle, Bora Gurel, Adam Stewart, Jenny King, Mona Parmar, Alison Turner, Florence Raynaud, Muneeb Mahmud, Christina Yap, Jonathan A. Pachter, Gordon B. Mills, Anna Minchom, Juanita Lopez, Susana N. Banerjee, Johann S. de Bono, Matthew Krebs, Udai Banerji
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): CT143.
https://doi.org/10.1158/1538-7445.AM2020-CT143
Published: 15 August 2020
View article titled, Abstract CT143: Phase I study of the combination of a RAF-MEK inhibitor CH5126766 and FAK inhibitor defactinib in an intermittent dosing schedule with expansions in <em>KRAS</em> mutant cancers
Journal Articles

Abstract CT188: Pharmacodynamic changes by durvalumab in combination with chemotherapy in women with untreated, advanced stage ovarian cancer

Shannon N. Westin, Sanghoon Lee, Li Zhao, Ying Yuan, Jimin Wu, Richard Hajek, Sara Sharafi, Larissa A. Meyer, Nicole D. Fleming, Amir Jazaeri, Robert L. Coleman, Karen H. Lu, Gordon B. Mills, Jianhua Zhang, Andrew Futreal, Anil K. Sood
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): CT188.
https://doi.org/10.1158/1538-7445.AM2020-CT188
Published: 15 August 2020
View article titled, Abstract CT188: Pharmacodynamic changes by durvalumab in combination with chemotherapy in women with untreated, advanced stage ovarian cancer
Journal Articles

Abstract NG14: Proteome instability is an immunogenic therapeutic vulnerability in mismatch repair deficient cancer

Nidhi Sahni, Daniel J. McGrail, Jeannine Garnett, Jun Yin, Hui Dai, David J. H. Shih, Guang Peng, David Menter, Melinda S. Yates, Scott Kopetz, Karen Lu, Russell Broaddus, Gordon B. Mills, Shiaw Y. Lin
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): NG14.
https://doi.org/10.1158/1538-7445.AM2020-NG14
Published: 15 August 2020
View article titled, Abstract NG14: Proteome instability is an immunogenic therapeutic vulnerability in mismatch repair deficient cancer